Dave Fornell, ITN Editor
Dave Fornell, ITN Editor

Dave Fornell is the editor of ITN and DAIC magazines

Blog | Dave Fornell, ITN Editor | HIMSS | March 24, 2016

New Trends and Technology at HIMSS 2016

The need for improved efficiency in healthcare and the new requirements of U.S. healthcare reform have rapidly made the Healthcare Information and Management Systems Society (HIMSS) annual meeting into one of the largest medical conferences in the world. More than 1,300 companies exhibited on the expo floor, covering IT for every medical specialty including cardiology, radiology and radiation oncology. 

The major themes this year included how to leverage technology to implement population health initiatives, analytics software, patient engagement, improve connectivity and data/image sharing between disparate IT systems and outside physicians, and how to improve workflow efficiency. 

Analytics software and population health appeared to be the poster children topics of HIMSS 2016. With all of healthcare now migrating to electronic medical record platforms, this data can be mined for business uses such as better management of inventory, procedural room use, imaging utilization, staff performance, radiation dose management, monitoring factors for patient satisfaction and to help identify bottlenecks in patient discharge, door-to-balloon times, STAT radiology reads and what contributes to poor or improved patient outcomes. This data has been available for years at many facilities, but it is the new level of analytics software integration that now makes data mining possible for all these things on one screen using one program. 

Examples of analytics software and how technology can improve workflow on PACS and cardiovascular information systems can be found in the video “What to Look for in PACS Workflow Efficiency.”

However, technology is now much more sophisticated than simply pulling data on what has already happened, and can now help predict what will happen. This is the premise of the new IT arena of population health management. If all the risk factors are known for poor clinical outcomes or that lead to re-admissions, these can be tracked using software for all patients to determine who should be allocated additional, scarce resources. This is especially true for high-cost, high-readmission conditions such as heart failure, COPD and diabetes, or high-volume emergency department (ED) patient presentations, such as chest pain. Population health software starts with pulling the patient’s history, current drugs, diagnoses codes and procedures from the electronic medical record. But, it goes beyond this data to pull relevant information such as socio-economic and environmental considerations based on a patient’s address, access to healthcare based on proximity to clinics or hospitals, how often their prescriptions are filled to determine medication compliance, weather conditions, previous lab results, imaging and procedural reports, and many other factors. The software compares these statistics to local, regional and national averages to determine if a patient is at a higher risk than others for everything from readmissions, bed sores and infection, or to triage which chest pain patients in a busy ED are the most likely to be suffering coronary ischemia rather than gastrointestinal distress.

Some software vendors are taking this model to the next level of predictive analytics using health system-wide data or regional health data exchanges to mine thousands of data points to determine which patients in a county or region would be ideal candidates for pre-emptive care. This includes identifying who might be qualified for CT lung cancer screenings, or who should receive calls from healthcare outreach programs to prevent everything from low-birth weight babies in low-income areas and identifying heart failure patients before they ever present with acute symptoms in an ED.

Watch a video of how the University of Mississippi is using population health to identify high-risk cardiac patients.

Patient engagement has become a major topic of discussion as providers try to figure out how to leverage IT to meet this Stage 3 Meaningful Use requirement. I spoke with third-party health IT experts and visited vendors on the HIMSS expo floor for demonstrations of their technology, which can be viewed in the video “Patient Engagement Technology for Imaging.”

Another Stage 3 requirement is the use of clinical decision support (CDS) software to help reduce the number of unnecessary or inappropriate exams. I received feedback from consultants and had examples of this technology demonstrated by vendors in the video “Examples of Clinical Decision Support for Cardiology and Radiology.”

Related Content

A chest CT scan of a 79-year-old woman who presented with fever, dry cough, and chest pain for three days. Her husband and daughter-in-law had been recently diagnosed with coronavirus disease. The patient expired 11 days after admission.(Courtesy of Song F, Shanghai Public Health Clinical Center, Shanghai, China) #COVID2019 #COVID19 #coronavirus #2019nCoV

A chest CT scan of a 79-year-old woman who presented with fever, dry cough, and chest pain for three days. Her husband and daughter-in-law had been recently diagnosed with coronavirus disease. The patient expired 11 days after admission.(Courtesy of Song F, Shanghai Public Health Clinical Center, Shanghai, China)

Feature | Coronavirus (COVID-19) | February 28, 2020
February 28, 2020 — The first in a series of medical imaging studies on novel coronavirus (COVID-19) was published on
AI vendor Infravision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID-19 #COVID19 #Coronavirus #2019-nCoV

AI vendor Infravision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | February 28, 2020
February 28, 2020 — New healthcare technologies are being implemented in the fight against the novel coronavirus (COV
 LucidHealth, a physician-owned and led radiology company, announced today that it is using an AI-powered diagnostic aid from leading AI vendor Aidoc to help prioritize and expedite treatment to patients with critical, life-threatening conditions
News | Artificial Intelligence | February 28, 2020
February 28, 2020 — LucidHealth, a physician-owned and led r
Qure.ai, a leading healthcare AI startup
News | Artificial Intelligence | February 27, 2020
February 27, 2020 — Qure.ai, a leading healthcare AI startup has ann
Emagine Solutions Technology's VistaScan portable ultrasound enables doctors to enhance patient care. Clinicians can diagnose in moments, saving time and lives at a fraction of the cost of a cart ultrasound machine

Emagine Solutions Technology's VistaScan portable ultrasound enables doctors to enhance patient care. Clinicians can diagnose in moments, saving time and lives at a fraction of the cost of a cart ultrasound machine. Photo credit: Tech Parks Arizona

News | Ultrasound Imaging | February 27, 2020
February 27, 2020 — Emagine Solutions Technology, an award-winnin
In a study of more than 1,000 patients published in the journal Radiology, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19) #COVID19 #COVID-2019 #2019nCoV #COVID-19

Chest CT images of a 29-year-old man with fever for 6 days. RT-PCR assay for the SARS-CoV-2 using a swab sample was performed on Feb. 5, 2020, with a positive result. (A column) Normal chest CT with axial and coronal planes was obtained at the onset. (B column) Chest CT with axial and coronal planes shows minimal ground-glass opacities in the bilateral lower lung lobes (yellow arrows). (C column) Chest CT with axial and coronal planes shows increased ground-glass opacities (yellow arrowheads). (D column) Chest CT with axial and coronal planes shows the progression of pneumonia with mixed ground-glass opacities and linear opacities in the subpleural area. (E column) Chest CT with axial and coronal planes shows the absorption of both ground-glass opacities and organizing pneumonia. Image courtesy of Radiology

News | Computed Tomography (CT) | February 26, 2020 | Melinda Taschetta-Millane and Dave Fornell
February 26, 2020 — In a study of m
 over the course of a week and a half #coronavirus #COVID19 #COVID-2019 #2019nCoV

29-year old male with unknown exposure history, presenting with fever and cough, ultimately requiring intensive care unit admission. (a) Axial thin-section non-contrast CT scan shows diffuse bilateral confluent and patchy ground-glass (solid arrows) and consolidative (dashed arrows) pulmonary opacities. (b) The disease in the right middle and lower lobes has a striking peripheral distribution (arrow). Image courtesy of Radiology 

News | Computed Tomography (CT) | February 26, 2020
February 26, 2020 — Mount Sinai Health System physicians—the
An illustration of the novel coronavirus (COVID-19) from the CDC. #coronavirus #COVID19 #COVID-2019 #2019nCoV

An illustration of the novel coronavirus (COVID-19) from the CDC.

Feature | Coronavirus (COVID-19) | February 25, 2020 | Dave Fornell, Editor